| Literature DB >> 31384824 |
S Zahra Sayyed-Alangi1, Meysam Nematzadeh2.
Abstract
BACKGROUND: The various extracts of Trifolium resupinatum (Persian clover) sprout was obtained by using different solvents and microwave assisted extraction in the present study. Then, the bifunctionalized nanoliposomes were prepared and added to soybean oil for evaluating their effect on deferring the oxidation process.Entities:
Keywords: Antioxidant; Nanoliposome; Persian clover sprout; Trifolium resupinatum
Year: 2019 PMID: 31384824 PMCID: PMC6661728 DOI: 10.1186/s13065-019-0594-7
Source DB: PubMed Journal: BMC Chem ISSN: 2661-801X
The composition of the designed formulations for nanoliposomes containing PCSE, lecithin and soybean oil
| Formulation | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| Extract (%) | 2 | 4 | 6 | 2 | 4 | 6 |
| Lecithin (%) | 5 | 5 | 5 | 5 | 5 | 5 |
| Soybean oil (%) | 30 | 30 | 30 | 35 | 35 | 35 |
The concentration of all the materials used in the formula calculated by w/w
Fig. 1The total phenolic content of various extracts from PCS (mg Gallic acid/g dry extract). Different letters indicate significant differences (p < 0.05)
DPPH free radical scavenging activity (%) in the various extracts of PCS
| Concentration (ppm) | Extract | |||
|---|---|---|---|---|
| Water | Acetone | Ethanol | Methanol | |
| 100 | 5.37 ± 1.75Ea | 16.12 ± 1.24Eb | 21.24 ± 2.10Ec | 24.98 ± 1.52Ed |
| 250 | 7.20 ± 2.21 Da | 20.25 ± 1.38Db | 31.45 ± 1.04Dc | 37.55 ± 1.30Dd |
| 500 | 9.02 ± 1.48Ca | 27.79 ± 2.03Cb | 42.75 ± 2.18Cc | 49.58 ± 0.95Cd |
| 750 | 11.26 ± 2.86Ba | 32.51 ± 0.31Bb | 52.78 ± 1.25Bc | 63.43 ± 0.58Bd |
| 1000 | 13.09 ± 2.10Aa | 41.17 ± 2.15Ab | 57.02 ± 1.76Ac | 71.88 ± 0.95Ad |
Different capital letters indicate significant difference in each column (p < 0.05)
Different small letters indicate significant difference in each row (p < 0.05)
Fig. 2Creaming index and microencapsulation efficiency of various formula of initial nanoliposomes. Different small letters in columns of similar colors indicate significant differences (p < 0.05)
Creaming index and microencapsulated efficiency of PCSEN, PCSEN-W and PCSE-WP
| Treatment | Creaming index | Encapsulation efficiency |
|---|---|---|
| PCSEN | 92 ± 1.50b | 85 ± 1.67b |
| PCSEN-W | 95 ± 1.10a | 90 ± 1.13a |
| PCSE-WP | 94 ± 1.70ab | 91 ± 1.13a |
Different small letters in each column indicate significant differences (p < 0.05)
The Z-average droplet size, PdI and zeta potential of PCSEN, PCSEN-W and PCSEN-WP
| Nanoliposome | Z-average (nm) | PdI | Zeta potential (mV) |
|---|---|---|---|
| PCSEN | 282.5 | 0.424 | − 56.9 |
| PCSEN-W | 481.7 | 0.531 | − 53.5 |
| PCSEN-WP | 491.2 | 0.541 | − 36.3 |
Fig. 3a Droplet size distribution of PCSEN; b droplet size distribution of PCSEN-W; c droplet size distribution of PCSEN-WP; d zeta potential of PCSEN; e zeta potential of PCSEN-W; f zeta potential of PCSEN-WP
Peroxide values (meq/kg oil) of different treatments from PSCE during 20 days at 63 °C
| Treatment | Day | |||||
|---|---|---|---|---|---|---|
| 0 | 4 | 8 | 12 | 16 | 20 | |
| Control | 0.093 ± 0.00Fa | 5.65 ± 0.13Ea | 11.05 ± 0.30 Da | 13.92 ± 0.42Ca | 20.15 ± 0.646Ba | 28.45 ± 0.97Aa |
| BHT-100 | 0.065 ± 0.00Fb | 1.35 ± 0.03Eh | 4.40 ± 0.30Dg | 7.85 ± 0.24Ch | 10.79 ± 0.347Bfg | 12.82 ± 0.438Ae |
| BHT-200 | 0.063 ± 0.00Fb | 1.20 ± 0.03Ei | 4.17 ± 0.11Dg | 7.60 ± 0.41Chi | 10.34 ± 0.332Bgh | 12.24 ± 0.42Aef |
| PSCE-100 | 0.045 ± 0.00Fg | 5.05 ± 0.11Eb | 7.36 ± 0.20Db | 9.56 ± 0.29Cb | 13.28 ± 0.417Bb | 16.45 ± 0.46Ab |
| PSCE-200 | 0.043 ± 0.00Fh | 3.95 ± 0.09Ec | 6.53 ± 0.30Dc | 8.92 ± 0.20Ccde | 12.42 ± 0.399Bbc | 16.05 ± 0.55Abc |
| PSCE-300 | 0.005 ± 0.001 fg | 3.55 ± 0.09Ed | 6.15 ± 0.27Dcd | 8.66 ± 0.26Cdef | 12.19 ± 0.392Bbcd | 15.79 ± 0.54Abc |
| PSCEN-100 | 0.055 ± 0.01Fcd | 2.53 ± 0.06Ee | 5.82 ± 0.16Dc | 9.33 ± 0.38Cbc | 12.58 ± 0.404Bbc | 15.96 ± 0.34Abc |
| PSCEN-200 | 0.056 ± 0.001Fc | 1.95 ± 0.04Eg | 5.17 ± 0.15Def | 8.52 ± 0.36Cef | 11.97 ± 0.385Bcde | 15.60 ± 0.53Abcd |
| PSCEN-300 | 0.053 ± 0.00Fde | 1.93 ± 0.04Eg | 5.35 ± 0.15Def | 8.42 ± 0.25Cefg | 11.84 ± 0.48Bdec | 15.08 ± 0.51Acd |
| PSCEN-W100 | 0.054 ± 0.05Fcde | 3.55 ± 0.08Ed | 6.05 ± 0.17Dd | 9.29 ± 0.28Cbc | 12.30 ± 0.295Bbcd | 15.84 ± 0.54Abc |
| PSCEN-W200 | 0.053 ± 0.00Fde | 1.95 ± 0.04Eg | 5.40 ± 0.15De | 8.40 ± 0.31Cfg | 11.50 ± 0.37Bde | 15.09 ± 0.42Abc |
| PSCEN-W300 | 0.055 ± 0.00Fcd | 2.15 ± 0.05Ef | 5.17 ± 0.15Df | 7.93 ± 0.24Cgh | 11.23 ± 0.36Bef | 14.64 ± 0.50Ad |
| PSCEN-WP100 | 0.050 ± 0.00Ff | 2.25 ± 0.05Ef | 5.15 ± 0.16Def | 7.09 ± 0.21Cij | 9.06 ± 0.20Bh | 12.85 ± 0.44Ae |
| PSCEN-WP200 | 0.052 ± 0.00Fe | 2.15 ± 0.05Ef | 4.25 ± 0.12Dg | 6.80 ± 0.31Cij | 8.92 ± 0.29Bhi | 11.54 ± 0.19Afg |
| PSCEN-WP300 | 0.056 ± 0.00Fc | 1.87 ± 0.04Eg | 3.85 ± 0.11Dh | 6.66 ± 0.20Cj | 8.64 ± 0.18Bi | 11.20 ± 0.38Ag |
Differences between small letters show significant differences between different samples in each column (p ≤ 0.05)
Differences between capital letters indicate significant difference in each row (p ≤ 0.05)
Thiobarbituric acid values (mg malonaldehyde/kg oil) of different samples of PCSE extracts, and BHT during 12 days at 63 °C
| Treatment | Day | |||||
|---|---|---|---|---|---|---|
| 0 | 4 | 8 | 12 | 16 | 20 | |
| Control | 0.033 ± 0.001Da | 0.042 ± 0.002Ca | 0.047 ± 0.002Cab | 0.052 ± 0.003Ca | 0.066 ± 0.001Ba | 0.075 ± 0.006Aa |
| BHT-100 | 0.023 ± 0.003Fb | 0.025 ± 0.001Eh | 0.030 ± 0.003Di | 0.034 ± 0.001Ce | 0.038 ± 0.002Bcd | 0.043 ± 0.004Acde |
| BHT-200 | 0.022 ± 0.001Eb | 0.027 ± 0.004Dgh | 0.029 ± 0.001Di | 0.033 ± 0.002Ce | 0.036 ± 0.001Bde | 0.040 ± 0.002Ade |
| PSCE-100 | 0.006 ± 0.000Ef | 0.032 ± 0.001Dbc | 0.037 ± 0.003Ce | 0.040 ± 0.002Bcd | 0.045 ± 0.003Ab | 0.043 ± 0.001ABbcde |
| PSCE-200 | 0.007 ± 0.000Ee | 0.029 ± 0.001DFg | 0.034 ± 0.001Cg | 0.036 ± 0.002BCde | 0.043 ± 0.002Abc | 0.039 ± 0.005ABe |
| PSCE-300 | 0.005 ± 0.003Dfg | 0.032 ± 0.002Cbc | 0.042 ± 0.001Abcd | 0.034 ± 0.003Be | 0.041 ± 0.004Abc | 0.043 ± 0.002Ac |
| PSCEN-100 | 0.007 ± 0.000Ee | 0.031 ± 0.001Dce | 0.033 ± 0.000Ch | 0.040 ± 0.002ABcd | 0.043 ± 0.002Ab | 0.037 ± 0.001Be |
| PSCEN-200 | 0.005 ± 0.000Fg | 0.032 ± 0.002CDbc | 0.035 ± 0.002BCfg | 0.039 ± 0.002Ad | 0.033 ± 0.000Df | 0.029 ± 0.002Ef |
| PSCEN-300 | 0.008 ± 0.002Ecd | 0.034 ± 0.004Bb | 0.031 ± 0.002Chi | 0.037 ± 0.000ABde | 0.041 ± 0.001Abc | 0.024 ± 0.003Dg |
| PSCEN-W100 | 0.008 ± 0.000Ede | 0.03 ± 0.002Dcef | 0.043 ± 0.003Bbc | 0.037 ± 0.001Cd | 0.048 ± 0.004ABb | 0.048 ± 0.003Ab |
| PSCEN-W200 | 0.007 ± 0.001Ede | 0.028 ± 0.000Dfgh | 0.049 ± 0.000Aa | 0.036 ± 0.004Cde | 0.045 ± 0.002Bb | 0.048 ± 0.005ABCbcd |
| PSCEN-W300 | 0.010 ± 0.000Dcd | 0.027 ± 0.000Ch | 0.041 ± 0.002Bcd | 0.043 ± 0.002ABbc | 0.043 ± 0.003ABb | 0.045 ± 0.002Abc |
| PSCEN-WP100 | 0.005 ± 0.003Fg | 0.028 ± 0.001Efgh | 0.040 ± 0.000Cd | 0.047 ± 0.002Aab | 0.033 ± 0.002Def | 0.042 ± 0.003Bde |
| PSCEN-WP200 | 0.005 ± 0.001Dfg | 0.027 ± 0.001Cgh | 0.036 ± 0.000Bf | 0.045 ± 0.003Aabc | 0.041 ± 0.003Abc | 0.044 ± 0.002Ac |
| PSCEN-WP300 | 0.006 ± 0.000Df | 0.029 ± 0.000CF | 0.033 ± 0.001Bghi | 0.039 ± 0.004Ad | 0.033 ± 0.004Bf | 0.037 ± 0.001Ae |
Differences between small letters show significant differences between different samples in each column (p ≤ 0.05)
Differences between capital letters indicate significant difference in each row (p ≤ 0.05)